Virus-encoded chemokine receptors - putative novel antiviral drug targets

Large DNA viruses, in particular herpes- and poxviruses. have evolved proteins that serve as mimics or decoys for endogenous proteins in the host. The chemokines and their receptors serve key functions in both innate and adaptive immunity through control of leukocyte trafficking, and have as Such a paramount role in the antiviral immune responses. It is therefore not surprising that viruses have found ways to exploit and subvert the chemokine system by means of molecular mimicry. By ancient acts of molecular piracy and by induction and suppression of endogenous genes, viruses have utilized chemokines and their receptors to serve a variety, of roles in viral life-cycle. This review focuses on the pharmacology of virus-encoded chemokine receptors. yet also the family of virus-encoded chemokines and chemokine-binding proteins will be touched upon. Key properties of the vir-us-encoded receptors, compared to their closest endogenous homologs, are interactions with a wider range of chemokines. which can act as agonists. antagonists and inverse agonists, and the exploitation of many signal transduction pathways. High constitutive activity is another key property of some - but not all - of these receptors. The chemokine receptors belong to the superfamily of G-protein Coupled 7TM receptors that per se are excellent drug targets. At present, non-peptide antagonists have been developed against many chemokine receptors. The potentials of the virus-encoded chemokine receptors as drug targets - ie. as novel antiviral strategies - will be highlighted here together with the potentials of the virus-encoded chemokines and chemokine-binding proteins as novel anti-inflammatory biopharmaceutical strategies. (C) 2004 Elsevier Ltd. All rights reserved.